Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Hims & Hers Health
HIMS
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.10
-0.18
-1.11%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Hims & Hers Health (HIMS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Hims & Hers Health (NYSE:HIMS) Stock
Hims & Hers Health Stock (NYSE: HIMS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 17, 2024
How Is The Market Feeling About Hims & Hers Health?
Benzinga Insights
Friday, September 13, 2024
Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (8 Ratings)
Benzinga Insights
B of A Securities Maintains Buy on Hims & Her...
Benzinga Newsdesk
Thursday, September 12, 2024
Smart Money Is Betting Big In HIMS Options
Benzinga Insights
Wednesday, September 11, 2024
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
Benzinga Neuro
Monday, September 09, 2024
Hims & Hers Health Inc. Files For Mixed Shelf...
Benzinga Newsdesk
Thursday, September 05, 2024
Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation
Vandana Singh
Wednesday, September 04, 2024
MHRA Finds No Evidence Supporting Link Betwee...
Benzinga Newsdesk
Thursday, August 29, 2024
Hearing Blog Post; Capitol Forum Reports Form...
Benzinga Newsdesk
Wednesday, August 28, 2024
Smart Money Is Betting Big In HIMS Options
Benzinga Insights
Tuesday, August 27, 2024
Why Hims & Hers Health Stock Is Falling
Henry Khederian
American Woodmark Reports Downbeat Results, Joins Snowflake And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Monday, August 26, 2024
Behind the Scenes of Hims & Hers Health's Latest Options Trends
Benzinga Insights
Thursday, August 22, 2024
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst
Lekha Gupta
The Latest Analyst Ratings For Hims & Hers Health
Benzinga Insights
Hims & Hers Health shares are trading higher ...
Benzinga Newsdesk
Needham Initiates Coverage On Hims & Hers Hea...
Benzinga Newsdesk
Monday, August 19, 2024
Looking Into Hims & Hers Health's Recent Short Interest
Benzinga Insights
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
Vandana Singh
Thursday, August 15, 2024
Insider Unloading: Oluyemi Okupe Sells Options, Realizes $69K
Benzinga Insights
Tuesday, August 13, 2024
Hims & Hers Health Unusual Options Activity For August 13
Benzinga Insights
Thursday, August 08, 2024
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Benzinga Insights
Wednesday, August 07, 2024
Deutsche Bank Maintains Hold on Hims & Hers H...
Benzinga Newsdesk
Tuesday, August 06, 2024
Analyst Expectations For Hims & Hers Health's Future
Benzinga Insights
Piper Sandler Reiterates Neutral on Hims & He...
Benzinga Newsdesk
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Monday, August 05, 2024
Hims & Hers Health Reports Better-Than-Expected Q2 Results: Details
Erica Kollmann
Hims & Hers Health Expects Q3 Revenue Of $375...
Benzinga Newsdesk
Hims & Hers Health Raises FY24 Revenue Guidan...
Benzinga Newsdesk
Hims & Hers Health shares are trading lower f...
Benzinga Newsdesk
Hims & Hers Health Q2 2024 GAAP EPS $0.06 Bea...
Benzinga Newsdesk
Thursday, August 01, 2024
What's Going On With HIMS Shares Today?
Vaishali Prayag
Lilly CEO Sees Weight-Loss Drug Shortage Endi...
Benzinga Newsdesk
Tuesday, July 30, 2024
Decoding Hims & Hers Health's Options Activity: What's the Big Picture?
Benzinga Insights
Monday, July 29, 2024
Hospital Business Recovery to Aid Haemonetics' Q1 Earnings
Zacks
Sunday, July 28, 2024
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Lekha Gupta
Friday, July 26, 2024
Hims & Hers Health shares are trading lower f...
Benzinga Newsdesk
How Is The Market Feeling About Hims & Hers Health?
Benzinga Insights
Wednesday, July 24, 2024
Quest Diagnostics' Haystack Oncology Forges New MRD Deal
Zacks
Tuesday, July 23, 2024
What's Going On With Hims & Hers Shares Today?
Vaishali Prayag
Here's How STERIS is Placed Ahead of Q1 Earnings
Zacks
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Novo's Weight-Loss Drug Wegovy Receives UK No...
Benzinga Newsdesk
Monday, July 22, 2024
Why Hims & Hers Heath Shares Are Surging Today
Vaishali Prayag
Hims & Hers Health shares are trading higher ...
Benzinga Newsdesk
Hims & Hers Shares Up 5.3%, Co. Earlier Annou...
Benzinga Newsdesk
Friday, July 19, 2024
Hims & Hers Health shares are trading lower f...
Benzinga Newsdesk
Hims & Hers Says 'Voluntarily Cooperating' Wi...
Benzinga Newsdesk
Hims & Hers Health Unusual Options Activity
Benzinga Insights
Thursday, July 18, 2024
Truist Securities Maintains Hold on Hims & He...
Benzinga Newsdesk
Show More
